3 completed. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 3 | 1 | Completed 1 |
Follow BK Virus Infection: new trials by email Literature Review of BK Virus Infection trials Research Report on BK Virus Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Posoleucel (Formerly Known as ALVR105; Viralym-M) in Kidney Transplant Patients With BK Viremia Posoleucel (formerly known as ALVR105) cells, Placebo (visually identical to Posoleucel) - BK Virus Nephropathy, BK Virus Infection | Phase 2 | Completed | AlloVir | 61 | 2021-03-22 | 2024-05-16 |
| Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant Posoleucel (ALVR105) - Adenovirus Infection, BK Virus Infection | Phase 2 / Phase 3 | Completed | AlloVir | 26 | 2021-01-15 | 2024-05-09 |
| A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant Recipients MAU868, Placebo - BK Virus Infection | Phase 2 | Completed | Vera Therapeutics, Inc. | 30 | 2020-08-05 | 2023-06-07 |
Adenoviridae Infections (1) · Cytomegalovirus Infections (1) · Epstein-Barr Virus Infections (1)
DNA Virus Infections (1) · Herpesviridae Infections (1) · Infections (1) · Tumor Virus Infections (1) · Virus Diseases (1)
Cell Count (1)
AlloVir (2) · Vera Therapeutics, Inc. (1)
United States (3) · Canada (1)